Injective, a Layer 1 blockchain, has remained in a narrow trading range for the past month, reflecting a bearish sentiment. The INJ price has entered a consolidation phase, signalling a lack of investor interest. This trend coincides with a broader market downturn as the crypto community anticipates the upcoming Altaris upgrade.